Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Toll-like receptors--sentries in the B-cell response.

Bekeredjian-Ding I, Jego G.

Immunology. 2009 Nov;128(3):311-23. doi: 10.1111/j.1365-2567.2009.03173.x. Review.

2.

Activating systemic autoimmunity: B's, T's, and tolls.

Shlomchik MJ.

Curr Opin Immunol. 2009 Dec;21(6):626-33. doi: 10.1016/j.coi.2009.08.005. Epub 2009 Sep 30. Review.

3.

Alveolar macrophages and lung dendritic cells sense RNA and drive mucosal IgA responses.

Bessa J, Jegerlehner A, Hinton HJ, Pumpens P, Saudan P, Schneider P, Bachmann MF.

J Immunol. 2009 Sep 15;183(6):3788-99. doi: 10.4049/jimmunol.0804004. Epub 2009 Aug 26.

4.

Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy.

Schmitz N, Dietmeier K, Bauer M, Maudrich M, Utzinger S, Muntwiler S, Saudan P, Bachmann MF.

J Exp Med. 2009 Aug 31;206(9):1941-55. doi: 10.1084/jem.20090199. Epub 2009 Aug 10.

5.

A cell biological view of Toll-like receptor function: regulation through compartmentalization.

Barton GM, Kagan JC.

Nat Rev Immunol. 2009 Aug;9(8):535-42. doi: 10.1038/nri2587. Epub 2009 Jun 26. Review.

6.

Endocytic sequestration of the B cell antigen receptor and toll-like receptor 9 in anergic cells.

O'Neill SK, Veselits ML, Zhang M, Labno C, Cao Y, Finnegan A, Uccellini M, Alegre ML, Cambier JC, Clark MR.

Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6262-7. doi: 10.1073/pnas.0812922106. Epub 2009 Mar 30.

7.

Immunostimulatory activity of haptenated proteins.

Palm NW, Medzhitov R.

Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4782-7. doi: 10.1073/pnas.0809403105. Epub 2009 Mar 2.

8.

Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.

Senti G, Johansen P, Haug S, Bull C, Gottschaller C, Müller P, Pfister T, Maurer P, Bachmann MF, Graf N, Kündig TM.

Clin Exp Allergy. 2009 Apr;39(4):562-70. doi: 10.1111/j.1365-2222.2008.03191.x. Epub 2009 Feb 16.

PMID:
19226280
9.

BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formation.

Eckl-Dorna J, Batista FD.

Blood. 2009 Apr 23;113(17):3969-77. doi: 10.1182/blood-2008-10-185421. Epub 2009 Jan 14.

10.

The coming of age of virus-like particle vaccines.

Jennings GT, Bachmann MF.

Biol Chem. 2008 May;389(5):521-36. Review.

PMID:
18953718
11.

Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.

Geeraedts F, Goutagny N, Hornung V, Severa M, de Haan A, Pool J, Wilschut J, Fitzgerald KA, Huckriede A.

PLoS Pathog. 2008 Aug 29;4(8):e1000138. doi: 10.1371/journal.ppat.1000138.

12.

Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and -extrinsic mechanisms.

Hou B, Reizis B, DeFranco AL.

Immunity. 2008 Aug 15;29(2):272-82. doi: 10.1016/j.immuni.2008.05.016. Epub 2008 Jul 24.

13.

The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens.

Chaturvedi A, Dorward D, Pierce SK.

Immunity. 2008 Jun;28(6):799-809. doi: 10.1016/j.immuni.2008.03.019. Epub 2008 May 29.

14.

T follicular helper (TFH) cells in normal and dysregulated immune responses.

King C, Tangye SG, Mackay CR.

Annu Rev Immunol. 2008;26:741-66. doi: 10.1146/annurev.immunol.26.021607.090344. Review.

PMID:
18173374
15.

B cell intrinsic TLR signals amplify but are not required for humoral immunity.

Meyer-Bahlburg A, Khim S, Rawlings DJ.

J Exp Med. 2007 Dec 24;204(13):3095-101. Epub 2007 Nov 26.

16.

Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen.

Caton ML, Smith-Raska MR, Reizis B.

J Exp Med. 2007 Jul 9;204(7):1653-64. Epub 2007 Jun 25.

17.

Toll-like receptors and innate immunity in B-cell activation and antibody responses.

Lanzavecchia A, Sallusto F.

Curr Opin Immunol. 2007 Jun;19(3):268-74. Epub 2007 Apr 12. Review.

PMID:
17433875
18.
19.

TLR9 signaling in B cells determines class switch recombination to IgG2a.

Jegerlehner A, Maurer P, Bessa J, Hinton HJ, Kopf M, Bachmann MF.

J Immunol. 2007 Feb 15;178(4):2415-20.

20.

TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses.

Heer AK, Shamshiev A, Donda A, Uematsu S, Akira S, Kopf M, Marsland BJ.

J Immunol. 2007 Feb 15;178(4):2182-91.

Supplemental Content

Support Center